Neurotech International Ltd (NTI) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.007x

Based on the latest financial reports, Neurotech International Ltd (NTI) has a cash flow conversion efficiency ratio of -0.007x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-38.33K ≈ $-27.12K USD) by net assets (AU$5.88 Million ≈ $4.16 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Neurotech International Ltd worth for the company's overall valuation and market capitalisation.

Neurotech International Ltd - Cash Flow Conversion Efficiency Trend (2015–2026)

This chart illustrates how Neurotech International Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Neurotech International Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Neurotech International Ltd ranked by their cash flow conversion efficiency. See Neurotech International Ltd debt service capacity to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
Arandu Investimentos S.A. SA:ARND3	-0.317x
Kwang Jin Ind. Co. Ltd KQ:026910	0.025x
Enero Group Ltd AU:EGG	0.062x
Zenta Group Company Limited Ordinary Shares NASDAQ:ZGM	N/A
Kresna Graha Investama Tbk PT JK:KREN	0.008x
Indian Terrain Fashions Limited NSE:INDTERRAIN	0.029x
Moatech Co. Ltd KQ:033200	0.005x
Citius Pharmaceuticals Inc NASDAQ:CTXR	-0.019x

Annual Cash Flow Conversion Efficiency for Neurotech International Ltd (2015–2026)

The table below shows the annual cash flow conversion efficiency of Neurotech International Ltd from 2015 to 2026. View Neurotech International Ltd stock quote for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2026-06-30	AU$611.14K ≈ $432.42K	AU$-4.22 Million ≈ $-2.99 Million	-6.912x	-126.31%
2025-06-30	AU$2.95 Million ≈ $2.09 Million	AU$-9.02 Million ≈ $-6.39 Million	-3.054x	-690.85%
2024-06-30	AU$11.90 Million ≈ $8.42 Million	AU$-4.60 Million ≈ $-3.25 Million	-0.386x	+75.78%
2023-06-30	AU$3.96 Million ≈ $2.80 Million	AU$-6.32 Million ≈ $-4.47 Million	-1.594x	+22.85%
2022-06-30	AU$1.43 Million ≈ $1.01 Million	AU$-2.96 Million ≈ $-2.09 Million	-2.067x	-244.48%
2021-06-30	AU$3.86 Million ≈ $2.73 Million	AU$-2.32 Million ≈ $-1.64 Million	-0.600x	-156.78%
2020-06-30	AU$-646.29K ≈ $-457.29K	AU$-682.83K ≈ $-483.15K	1.057x	+112.36%
2019-06-30	AU$297.41K ≈ $210.44K	AU$-2.54 Million ≈ $-1.80 Million	-8.551x	-1095.71%
2018-06-30	AU$4.23 Million ≈ $2.99 Million	AU$-3.03 Million ≈ $-2.14 Million	-0.715x	+1.59%
2017-06-30	AU$4.30 Million ≈ $3.04 Million	AU$-3.12 Million ≈ $-2.21 Million	-0.727x	-1239.04%
2016-06-30	AU$14.48 Million ≈ $10.25 Million	AU$-785.79K ≈ $-555.99K	-0.054x	+91.75%
2015-12-31	AU$1.29 Million ≈ $916.07K	AU$-851.21K ≈ $-602.29K	-0.657x	--

About Neurotech International Ltd

AU:NTI Australia Biotechnology

Market Cap

$16.01 Million

AU$22.62 Million AUD

Market Cap Rank

#25891 Global

#1143 in Australia

Share Price

AU$0.01

Change (1 day)

+7.69%

52-Week Range

AU$0.01 - AU$0.02

All Time High

AU$0.48